Digital Workshop: Autodoc Launches the Autodoc Club Innovative Platform
Autodoc, the benchmark in the online retailing for car spare parts in Europe, is now offering its customers and interested parties an innovative platform for the maintenance of their own car under the name “Autodoc Club”. Thanks to its features, it is unique on the market. The platform, which is available in 26 European countries, contains over 1,300 professional PDF repair instructions in all national languages, plus 2,240 detailed video tutorials. In addition, there is a whole range of other useful functions, such as the integrated maintenance protocol for your own car. This opens up new possibilities for planning repairs and controlling costs. The Autodoc Club app is scheduled for release for Android and iOS operating systems at the beginning of 2020, and bundles on mobile devices all the Club website functions for smartphone and tablet users.
One-stop shop for advice, service and parts
Autodoc’s “Autodoc Club” now offers its customers an innovative platform that provides a wide range of services related to the repair and maintenance of cars. In addition to instructions in the form of PDFs and video tutorials, Autodoc Club offers various other features: users can not only store their car model in their profile, but also keep a maintenance log, receive reminders for the replacement of consumables or save workshop information.
The main component of the new Autodoc Club is a collection of over 1,300 PDF repair manuals and 2,240 video tutorials on individual repairs. A search function enables the customer to find the right manual for their car for the upcoming project. If a manual is not yet available, it can be requested directly from the Autodoc specialists.
Professional advice and convenient purchase of spare parts
The instructions provide direct access to the Autodoc online shop. The user can order all required parts conveniently in the spare parts dealer’s online shop. If a tool is missing, it can also be ordered directly in the online shop. In case of questions regarding repairs or spare parts, the customer can contact specialists such as car mechanics or technicians directly in the forum at any time. Autodoc Club therefore offers an integrated one-stop solution for car owners who want to repair their car themselves or obtain comprehensive information and buy spare parts directly and inexpensively.
“For the layman, car parts are mostly products that require explanation. From our experience, we know that many customers often have questions and need advice from experts. We now offer such support with the easy-to-use and integrated Autodoc Club platform. Every car owner can see how a repair is done, get help and decide for themselves what support they need from their local workshop. In any case, they can always order parts and tools conveniently from the Autodoc online shop without having to search the Internet for them”, explains Autodoc Managing Director, Alexej Erdle.
Free platform for car-related services
Additional features such as a maintenance log and a reminder function for changing consumables round off the offer and also help to avoid unnecessary costs. As a result, your car always stays in top condition. In the personal area, the user can also store vehicle documents, vehicle insurance policies and their own notes, so that all documents relating to their car are always at hand. And from the beginning of 2020, this will also be possible when on the go and travelling using your smartphone.
The use of the platform is unlimited and independent of placing an order. The creation of a free user account is only required for the personal assistant. Existing registration data for the Autodoc online shop also work on the new portal. Any car data already entered in the store account will also be transferred automatically when registering for Autodoc Club with the same account.
About Autodoc
Autodoc is Europe's leading online dealer for car spare parts. As the fastest-growing company in this sector with sales growth of 63% in the financial year 2018 to around EUR 415 million (2017: EUR 254 million), Autodoc aims to further expand its position. Thanks to its successful expansion, Autodoc is now represented in 25 other European countries in addition to Germany. Autodoc pursues a strong customer focus through social media campaigns, technical support in the respective national language and a current demand-oriented range of almost 2.5 million products from 545 brand manufacturers for 128 car brands. Autodoc GmbH is based in the Berlin district of Lichtenberg and is fully owner-managed. In addition to its headquarters, the company opened a representative office on Kurfürstendamm in May 2019.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005090/en/
Contact information
Thomas Casper
Head of Press and Public Relations & Communication
Tel.: +49-30-2084-78-237
E-mail: t.casper@autodoc.eu
www.autodoc.de
cometis AG
Matthias Kunz
Tel.: +49-611-20-585-564
kunz@cometis.de
www.cometis.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom